About this trial
The Comprehensive Lung Center (CLC) at the University of Pittsburgh Medical Center (UPMC Health System) provides patients with any type of breathing or lung disorder a full range of diagnostic and therapeutic services. The Emphysema/COPD Research Center (ECRC) is a specialty clinic, within this center, that attempts to advance the understanding of emphysema and to evaluate new therapies for patients with emphysema. The Emphysema Research Registry will enable pulmonary research physicians to: 1) gather information and create a research registry of people who have been diagnosed with emphysema; 2) utilize this research registry with the purpose of conducting research that attempts to advance the understanding of emphysema and to evaluate new therapies; and, 3) use the research registry to identify potential candidates for future research programs. These aims will be achieved by the collection of DNA (genetic material)for analysis and storage in addition to pulmonary function tests and other medical information.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Patients would be required to have COPD based on at least one of the following: clinical history, pulmonary function results, or radiographic results.
Disqualifiers
none
Trial population
Current and former smokers with a 10 pack year tobacco history.
Trial design
Cohort
Other
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
To gather information and create a research registry of people who have been diagnosed with emphysema and a control cohort of research participants without lung diseases,
This research registry will allow us to to advance the understanding of emphysema and to evaluate new therapies for patients with emphysema.
Secondary outcomes
To continue communications with past, present, and future research participants.
To utilize this research registry with the purpose to learn more about the pathogenesis of emphysema and the efficacy of new therapies, and to provide a mechanism for improving the quality of treatment for emphysema and advance the field.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.